Titan Pharmaceuticals
TTNP
#10793
Rank
โ‚ฌ5.39 M
Marketcap
4,05ย โ‚ฌ
Share price
-3.76%
Change (1 day)
20.02%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -4,00ย โ‚ฌ

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -3,86ย โ‚ฌ. In 2023 the company made an earnings per share (EPS) of -6,51ย โ‚ฌ an increase over its 2022 EPS that were of -13,35ย โ‚ฌ.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-4,00ย โ‚ฌ
2023-6,51ย โ‚ฌ-51.22%
2022-13,35ย โ‚ฌ-15.61%
2021-15,82ย โ‚ฌ-81.37%
2020-84,92ย โ‚ฌ-77.52%
2019-377,84ย โ‚ฌ-56.32%
2018-865,04ย โ‚ฌ-59.51%
2017-2.137ย โ‚ฌ-371.81%
2016786,08ย โ‚ฌ-144.35%
2015-1.772ย โ‚ฌ300%
2014-443,07ย โ‚ฌ-121.54%
20132.057ย โ‚ฌ-151.38%
2012-4.003ย โ‚ฌ-11.54%
2011-4.526ย โ‚ฌ188.89%
2010-1.567ย โ‚ฌ-10%
2009-1.741ย โ‚ฌ
2007-7.137ย โ‚ฌ-2.38%
2006-7.311ย โ‚ฌ-39.13%
2005-12.010ย โ‚ฌ-16.87%
2004-14.447ย โ‚ฌ-22.43%
2003-18.625ย โ‚ฌ4.9%
2002-17.754ย โ‚ฌ61.9%
2001-10.966ย โ‚ฌ-13.7%
2000-12.707ย โ‚ฌ72.14%
1999-7.382ย โ‚ฌ-35.87%
1998-11.511ย โ‚ฌ-1824.71%
1997667,42ย โ‚ฌ-102.4%
1996-27.865ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
7,68ย โ‚ฌ-298.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
6,17ย โ‚ฌ-259.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-3,56ย โ‚ฌ-7.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
0,81ย โ‚ฌ-120.96%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-0,21ย โ‚ฌ-94.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-3,74ย โ‚ฌ-2.96%๐Ÿ‡บ๐Ÿ‡ธ USA